Navigation Links
AIDS Sufferers Protest against Proposed Patent for Tenofovir

About 150 people which included some AIDS sufferers, held protests today against the proposed move of US biotech company to patent its anti-HIV drug, Tenofovir, in India. // The demonstrators alleged that this move could halt the local production of the generic equivalent.

The company, Gilead Sciences Inc., has applied for an Indian patent on the drug tenofovir. The drug has been available in India as the generic tenofovir disoproxil fumarate since last year.

Some demonstrators beat drums and carried placards reading ‘Patients against Patents,’ and ‘Lives before Profits.’ Some wore T-shirts with the message: ‘We are HIV positive.’

The protestors were briefly detained by the police before being allowed to go home.

According to Loon Gangte, a spokesman for the Delhi Network of Positive People. ‘For many of us living with HIV/AIDS, newer drugs like tenofovir offer a new hope of continuing treatment. With patents interfering with our lives, we have no choice but to oppose them.’

Delhi Network of Positive People, along with another anti-AIDS organization, the Indian Network for People Living With HIV/AIDS, filed an application with the New Delhi Patent Office yesterday opposing Gilead’s request.

Gilead has been offering tenofovir in treatment programmes to eligible developing countries.

The number of AIDS infected people in India is estimated to be about 5.21 million the second only to South Africa.

Medecins Sans Frontiers, an international medical aid agency providing technical support to the Indian groups in their legal battle has said that patenting in India would exclude millions of people from access to essential medicines.

According to them ‘TDF is clearly emerging as an important drug in the treatment of people living with HIV/AIDS.’

And therefore if Gilead were to be granted a patent in India for TDF, its generic production would be forced to h alt, making it more expensive and less easily available.

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Do Asthma Sufferers Lack Physical Activity?
3. Asthma Sufferers Lacking Physical Activity
4. Hope for Dust Mite Allergy Sufferers
5. Promise for Soya Allergy Sufferers
6. Zambia Struggling To Identify AIDS Sufferers
7. Celiac Disease Sufferers See an End to their Misery
8. AIDS Sufferers Turn to British Doctor to Prolong their Survival
9. Exercise DVD Available For COPD Sufferers
10. Sleep Apnea Sufferers-Viagra May Make The Condition Worse
11. Allergy Sufferers Pass on Allergies to their Children
Post Your Comments:

(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: